Clincosm LogoSign in Get a demo

eosinophilic gastritis

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Eosinophilic Gastritis, Eosinophilic Duodenitis, Eosinophilic Gastrointestinal Disease Trial (Dupilumab Dose 1, Dupilumab Dose

Not yet recruiting
  • Eosinophilic Gastritis
  • +2 more
  • Dupilumab Dose 1
  • +2 more
  • (no location specified)
Apr 14, 2023

Measures in Eosinophilic Gastrointestinal Disorders Across Ages

Recruiting
  • Eosinophilic Gastrointestinal Disorders (EGIDs)
  • +4 more
    • Rogers, Arkansas
    • +17 more
    Jan 31, 2023

    Study of Gastric Motility in EG

    Recruiting
    • Eosinophilic Gastritis
    • +2 more
      • Chicago, Illinois
      • +2 more
      Dec 16, 2022

      Eosinophilic Gastritis, Eosinophilic Gastroenteritis Trial in Worldwide (Benralizumab, Placebo)

      Recruiting
      • Eosinophilic Gastritis
      • Eosinophilic Gastroenteritis
      • Benralizumab
      • Placebo
      • Phoenix, Arizona
      • +85 more
      Aug 4, 2022

      Eosinophilic Gastritis, Eosinophilic Duodenitis Trial in United States (AK002, Placebo)

      Recruiting
      • Eosinophilic Gastritis
      • Eosinophilic Duodenitis
      • Birmingham, Alabama
      • +73 more
      Dec 9, 2021

      Eosinophilic Gastritis, Enteritis, and Colitis inMulti-Site

      Completed
      • Eosinophilic Esophagitis
      • +3 more
        • Little Rock, Arkansas
        • +5 more
        Sep 27, 2021

        Eosinophilic Gastritis, Eosinophilic Duodenitis Trial in United States (lirentelimab (AK002), Placebo)

        Active, not recruiting
        • Eosinophilic Gastritis
        • Eosinophilic Duodenitis
        • lirentelimab (AK002)
        • Placebo
        • Birmingham, Alabama
        • +59 more
        Jul 28, 2021

        Eosinophilic Gastritis, Eosinophilic Gastroenteritis, Eosinophilic Duodenitis Trial in United States (AK002)

        Active, not recruiting
        • Eosinophilic Gastritis
        • +2 more
        • Phoenix, Arizona
        • +16 more
        Jun 21, 2021

        Eosinophilic Gastritis, Eosinophilic Duodenitis Trial in United States (lirentelimab)

        Enrolling by invitation
        • Eosinophilic Gastritis
        • Eosinophilic Duodenitis
        • Gilbert, Arizona
        • +24 more
        Jan 6, 2021

        Eosinophilic Gastritis, Eosinophilic Gastroenteritis Trial in United States (AK002, Placebo)

        Completed
        • Eosinophilic Gastritis
        • Eosinophilic Gastroenteritis
        • Phoenix, Arizona
        • +20 more
        Jun 10, 2020

        Eosinophilic Esophagitis, Eosinophilic Gastritis, Eosinophilic Enteritis Trial in Little Rock

        Withdrawn
        • Eosinophilic Esophagitis
        • +3 more
          • Little Rock, Arkansas
            Arkansas Children's Hospital
          Jun 16, 2016